According to a new study, the all-cause mortality risk was almost 60% higher in patients with type 2 diabetes taking insulin-releasing sulfonylurea tablets, when compared with patients taking metformin.
The result is scary. This is an observational study, and correlation doesn’t prove causation. But it may very well be real.
Most new-onset type 2 diabetics have many times higher levels of insulin in their blood than healthy people have. They have pathologically high levels of insulin. Taking sulfonylureas makes your insulin levels even more pathologically elevated. Is it a coincidence that those treated then live shorter lives? My guess: no.
Discuss the benefit of your therapy with your doctor as needed – do not make any changes on your own.